Table 1.
Age Groups | Net Change 2 2030 vs. 2015 |
ASR 3 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
<45 | 45–54 | 55–64 | 65–74 | ≥75 | Total | ||||||||
N | % 1 | N | % 1 | N | % 1 | N | % 1 | N | % 1 | N | |||
Incidence 2015 | 48 | 10.8 | 80 | 17.9 | 110 | 24.7 | 92 | 20.7 | 115 | 25.9 | 445 | 22.4 | |
Incidence 2030 | 34 | 9.8 | 55 | 15.8 | 78 | 22.4 | 89 | 25.6 | 92 | 26.4 | 348 | −21.80% | 14.8 |
Mortality 2015 | 9 | 3.3 | 25 | 9.4 | 50 | 18.8 | 65 | 24.4 | 117 | 43.9 | 266 | 14.0 | |
Mortality 2030 | 6 | 2.5 | 20 | 8.4 | 39 | 16.4 | 60 | 25.2 | 113 | 47.5 | 238 | −10.53% | 10.3 |
1 Percentage corresponds to row percentage. 2 Change: Percentage variation in the number of OC cases between 2030 and 2015. 3 ASR: Age—standardized rates to the European Standard Population per 100,000 women-years.